Danahy Kevin Patrick's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Nov 17, 2023
- Accession no.
- 0001437749-23-032410
- Filed
- Nov 17, 2023
- Trade date
- Nov 16, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $35.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Danahy Kevin PatrickCIK 0001913245 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | Common Stock | PPurchaseAcquired | +4,781 | $6.52 | +$31,172.12 | 35,275 | Direct | |
| Nov 16, 2023 | Common Stock | PPurchaseAcquired | +600 | $6.51 | +$3,906 | 35,875 | Direct | |
| Nov 16, 2023 | Common Stock | PPurchaseAcquired | +12 | $6.50 | +$78 | 35,887 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.